Related Experiment Video
Updated: May 1, 2026

Acetylcholine Re-Challenge After Intracoronary Nitroglycerine Administration
Published on: April 4, 2022
Current options for treatment of chronic coronary artery disease
Sotirios N Prapas1, Kosmas Tsakiridis1, Paul Zarogoulidis1
11 Cardiac Surgery Department, Director of "Henry Dunant" Hospital, Athens, Greece ; 2 Cardiothoracic Surgery Department, "Saint" Luke Private Hospital, Thessaloniki, Panorama, Greece ; 3 Pulmonary Department-Oncology Unit, "G. Papanikolaou" General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece ; 4 Surgery Department (NHS), University General Hospital of Alexandroupolis, Alexandroupolis, Greece ; 5 Internal Medicine Department, "Theageneio" Anticancer Hospital, Thessaloniki, Greece ; 6 Pathology Department, "G. Papanikolaou" General Hospital, Thessaloniki, Greece.
Insights
For chronic coronary artery disease (CAD), revascularization is beneficial only if ischemia is proven. Treatment decisions for CAD patients hinge on symptoms, ischemia evidence, and coronary anatomy complexity.
Area of Science:
- Cardiology
- Interventional Cardiology
- Cardiac Surgery
Background:
- Chronic coronary artery disease (CAD) management involves complex treatment decisions.
- Key considerations include revascularization appropriateness and method selection.
- Patient symptoms, ischemia evidence, and coronary anatomy guide these choices.
Purpose of the Study:
- To discuss primary issues in treating chronic CAD patients.
- To outline criteria for revascularization appropriateness and method selection.
- To present current treatment options for CAD.
Main Methods:
- Review of clinical criteria for revascularization decisions.
- Evaluation of factors influencing prognosis (left ventricular function, stenosis extent, ischemic burden).
- Comparison of surgical versus interventional approaches.
Main Results:
- Revascularization offers no benefit for patients with symptoms but no ischemia.
- Proven ischemia indicates benefit from revascularization.
- Prognosis is determined by left ventricular function, number of stenosed arteries, and ischemic burden.
Conclusions:
- Treatment decisions for chronic CAD must balance symptom persistence, ischemia, and anatomical complexity.
- Revascularization is indicated when ischemia is present and symptoms persist despite medical therapy.
- The choice between surgical and interventional revascularization depends on individual patient factors and current treatment options.
Abstract:
The primary issues must be discussed regarding the decision making of treating a patient with chronic coronary artery disease (CAD), are the appropriateness of revascularization and the method which will be applied. The criteria will be the symptoms, the evidence of ischemia and the anatomical complexity of the coronary bed. Main indications are persistence of symptoms, despite oral medical treatment and the prognosis of any intervention. The prognosis is based on left ventricular function, on the number of coronary arteries with significant stenosis and the ischemic burden. For patients with symptoms and no evidence of ischemia, there is no benefit from revascularization. If ischemia is proven, revascularization is beneficial. If revascularization is decided, the next important issue must be taken under consideration is the choice of the appropriate method to be applied, surgical or interventional approach. Current treatment options will be presented.
Related Concept Videos
Coronary Artery Disease V: Interprofessional Care
Atherosclerosis III: Management
Acute Coronary Syndrome IV: Interprofessional Care
Angina IV: Management
Peripheral Artery Disease III: Interprofessional Care
Coronary Artery Disease IV: Preventive Measures

